Introduction
The causal relationship between elevated.circulating prolactin concentrations and suppressed LH secretion observed in many amenorrhoeic women (McNeilly, 1979) has also been demonstrated in laboratory rats following artificial induction of hyperprolactinaemia (McNeilly, 1980) . Ovariecto¬ mized female rats have been used to study the central anti-gonadotrophin effects of prolactin because the marked inhibition of serum LH levels in the absence of the ovaries indicates that pro¬ lactin can act directly on the hypothalamic/pituitary axis (Beck, Engelbart, Gelato & Wuttke, 1977; Grandison et al., 1977; Vasquez, Nazian & Mahesh, 1980; Carter & Whitehead, 198la) .
Investigations of the mechanism(s) by which prolactin exerts its central effects have suggested that the inhibition of LH secretion occurs via a blockade of release of hypothalamic LH-RH and that an attenuation of pituitary responsiveness to LH-RH is not involved (Gudelsky, Simpkins, Mueller, Meites & Moore, 1976; Grandison et al., 1977; Gil-Ad et al., 1978; Vasquez et al., 1980; Carter & Whitehead, 1981b) . However, this conclusion should be treated with caution since previous studies have involved only isolated determinations of pituitary responsiveness or LH-RH release, whereas the inhibition of LH secretion during hyperprolactinaemia in ovariectomized rats has been shown to be a dynamic process with an acute onset (Gudelsky et al., 1976; Flint & Ensor, 1981) , but limited duration Grandison et al., 1977) Serum and perfusate LH concentrations and serum concentrations of prolactin were measured by radioimmunoassays using the procedures outlined by the NIH, and are expressed in terms of NIAMDD-rat-LH-RPl and NIAMDD-rat-PRL-RP2, the sensitivities being 10 ng/ml and 1 ng/ml respectively. The inter-and intra-assay variations were calculated to be, respectively, 10-0 and 9-0% for LH and 10-3 and 8-7% for prolactin. The concentration of LH-RH in hypothalamic extracts was assayed by a single-antibody radioimmunoassay (Jeffcoate, Fraser, Holland & Gunn, 1974) Carter & Whitehead (1981c) . Isolated hemi-pituitary glands were perfused at a rate of 0-2 ml/min with Krebs-Ringer bicarbonate, containing bovine serum albumin (2-5 g/1) and glucose (2 g/1). Perfusate fractions were collected every 10 min and the glands were challenged with two 5-min pulses of LH-RH (10 ng/ml) which were separated by an interval of 1 h.
LH-RH content of the medial-basal hypothalamus. Whole brains were excised and placed in ice. The medial-basal hypothalamus (MBH) consisting of a block of tissue approximately 1 mm in all planes around the median eminence (mean ± s.e.m. weight, 9-2 ± 1-8 mg), was dissected out within 2 min of killing. The tissue was weighed immediately and the LH-RH extracted according to the rapid method described by Koch & Baram (1976 (Text-fig. 2 ). Although the initial treatment resulted in a significant inhibition of serum LH in both groups, and the absolute heights of the LH-RH induced surges of LH were uniformly lower in the treated animals, the increment of LH secretion in response to LH-RH was similar in all the groups. Serum prolactin levels were raised after domperidone treatment, but no changes in the prolactin concentrations were observed after the LH-RH stimulus (Text- fig. 2 ). fig. 4a ), although the responsiveness of the 7-day group did appear to be lower than that of the vehicle-treated controls. A significant inhibition of pituitary responsiveness of pulses of LH-RH was observed, however, after 9 days of domperidone treatment, (Vasquez et al., 1980) .
Since the changes in pituitary responsiveness during sub-chronic hyperprolactinaemia do not correlate with the inhibition of LH secretion, it appears that an impairment of LH-RH secretion is responsible for the low LH levels. However, the results of the present study failed to produce evidence for a hypothalamic action of prolactin, in that the LH-RH content of the medio-basal hypothalamus was not significantly modified by domperidone treatment. However, experiments by McNeilly, Sharpe, Davidson & Fraser (1978) , which also indicated that the effects of hyperpro¬ lactinaemia on LH release in male rats was mediated by changes in LH-RH secretion, similarly failed to show any alteration in the hypothalamic LH-RH content. Marchetti & Labrie (1982) showed that hyperprolactinaemia, induced by pituitary transplants, slightly reduced pituitary binding of an LH-RH analogue in ovariectomized rats after 14 days, although concomitant oestrogen treatment markedly enhanced this inhibitory effect and led to much higher plasma pro¬ lactin levels. Such results also indicate that hyperprolactinaemia may alter LH-RH secretion, since this peptide is known to regulate its own receptors (Clayton & Catt, 1981 
